The current price of human papillomavirus, or HPV quadrivalent vaccine, is about $838 per injection, and the total price is about $2,500 for three injections completed within six months under normal circumstances, with some minor variations in cost in different geographic areas and at different levels of hospitals.
HPV vaccine is the abbreviation of cervical cancer vaccine, which is mainly used for the prevention of cervical cancer, and is divided into bivalent, quadrivalent and nine-valent. The quadrivalent vaccine has a protective effect against the four subtypes of HPV6, HPV11, HPV16, and HPV18 infections, which can reduce the chances of warts infection while preventing cervical cancer.
The main suitable vaccination population is women aged 9 to 45 years old. It is recommended to have cervical cancer screening before vaccination and regular routine screening is also required after vaccination. Due to the different levels of hospitals and regional consumption levels, the price will vary and need to be based on the charges of the local medical institutions.